Clinical trial
A Prospective Study of Higher Neural Control Changes Following Intra-detrusor Injection of Onabotulinumtoxin-A in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.
NCT03033355 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Higher Neural Control Changes Following Intra-detrusor Injection of Onabotulinumtoxin-A in Patients With Multiple Sclerosis and Lower Urinary Tract Symptoms.
- Lead sponsor
- The Methodist Hospital Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- March 31, 2019
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
detrusor, overactive, lower urinary tract symptoms, multiple sclerosis, neurogenic bladder, urge incontinence